IntelliDose is a complete oncology solution that Interfaces, as needed, or fully Integrates with other related applications.
As an integrated product, IntelliDose is capable of exchanging information with other systems and devices to reduce errors and eliminate duplicate data entry. IntelliDose offers the following interface solutions as options:
IntelliDose can receive HL-7 messages through its proprietary IntelliLink interface solution. IntelliLink enables IntelliDose to communicate with host EMR systems, laboratory information systems, pharmacy systems and any other HL-7 compliant interface.
IntelliDose is scalable to any size of oncology practice and so are its interface offerings. The IntelliDose design enables easy deployment of a range of interfaces to meet each client’s specific needs. These include inbound interfaces of demographic and lab data to detailed allergy, medication, and metrics information. There are also a variety of outbound interfaces to pass text documents of chemotherapy orders and nurse notes back to an EMR, as well as detailed drug administrations.
IntelliDose is capable of linking clinical oncology information within patient EMRs and PM tools to help reduce dosing errors, procedural flaws, and adverse drug interactions. As a result, to fully integrate IntelliDose into existing systems, IntrinsiQ has established partnerships with the leading hospital information systems, EMRs, and PM vendors. Only IntelliDose supports end-to-end care of cancer patients maintaining safety, saving staff time, maximizing reimbursement, and reducing operating costs.